GlassScriptPhysician profile
Jay C Shiao
NPI 1063947653
$3,315.85
in general payments reported to CMS, 2019-2025
9 companies · $850 in 2025
The $850 reported for 2025 was more than what 81% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.29 · 2022: $477 · 2023: $167 · 2024: $1,791 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,990 · Food and Beverage: $748 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,990.44 |
| Food and Beverage | $748.10 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $1,575.41 | 2024 | Elekta Medical Linear Accelerator, Flexitron Hdr |
| Siemens Medical Solutions USA, INC. | $691.48 | 2025 | Varian Ethos Treatment Planning |
| Boston Scientific Corporation | $546.33 | 2020-2025 | Spaceoar System, Spaceoar Vue System - 10ml, Spaceit Hydrogel System |
| Bioprotect Medical, INC. | $118.19 | 2024 | Bioprotect Balloon Implant System |
| Mim Software INC. | $103.00 | 2023 | Maestro |
| Palette Life Sciences, INC. | $93.12 | 2022 | |
| Stryker Corporation | $87.06 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Teleflex LLC | $32.77 | 2025 | Barrigel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Shiao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.